Pharmaceutical / Drug Definition :
Inhibits thrombus by preventing conversion of prothrombin to thrombin and fibrinogen to fibrin, preventing clot formation. Doesn't lyse existing clot, but prevents clot enlargement and extension.
In the United States, Heparin Sodium is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Heparin Sodium.
FDA Label Requirements and Exceptions
FDA Import Information
Heparin Sodium (Heparin Sodium Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Heparin Sodium (Heparin Sodium Suppliers)
- Processors Heparin Sodium
- Repackers Heparin Sodium
- Relabelers Heparin Sodium
- Exporters Heparin Sodium
- Importers Heparin Sodium
For more information about Heparin Sodium, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.